Author
@LogicalThesis LogicalThesis
grade Ax.com/LogicalThesis ↗
Rigorous bottom-up small-cap healthcare/AI thesis builder with disciplined position sizing
Develops and tickers high-conviction fundamental long theses
trader score
+2.21
hit rate
65%
mean α
+1.63%
signals 14d
104
Grade = how their written analysis reads (A best). Trader score = how their last-20 timestamped calls performed vs SPY.
Their picks, scored
Across their last 20 scored bets: 65% hit rate, +1.63% mean alpha, trader score +2.21. Their last-14d mentions, direction-adjusted, have moved -0.3% since posting (mean over 39 mentions with price data).
Recent signals15receipts included
| date (PT) | ticker | author | sent | what they said | since then | receipt |
|---|---|---|---|---|---|---|
| 2026-08-28 | · | @LogicalThesis | · | Warns that a lull before broader robotics adoption poses near-term risk to AI-related stocks. | · | tweet ↗ |
| 2026-08-28 | · | @LogicalThesis | · | Expects long-term AI growth but warns current stock prices face short- and medium-term volatility. | · | tweet ↗ |
| 2026-08-28 | · | @LogicalThesis | · | Doubts linear adoption growth can support current valuations without another breakthrough. | · | tweet ↗ |
| 2026-08-28 | NVDA | @LogicalThesis | +0.00 | Notes QQQ gained only 1.5% since July 22 despite a strong NVDA quarter. | — | tweet ↗ |
| 2026-08-28 | QQQ | @LogicalThesis | -0.20 | Notes QQQ gained only 1.5% since July 22 despite a strong NVDA quarter. | — | tweet ↗ |
| 2026-08-28 | · | @LogicalThesis | · | Says even intensive AI usage may be insufficient to justify sector valuations. | · | tweet ↗ |
| 2026-08-28 | · | @LogicalThesis | · | Rejects a 99.9% market-size assumption as drastically unrealistic. | · | tweet ↗ |
| 2026-08-28 | · | @LogicalThesis | · | Warns AI stocks could fall if later adoption phases are delayed and demand takes time to recover. | · | tweet ↗ |
| 2026-08-28 | · | @LogicalThesis | · | Develops a multi-year thesis that AI usage growth may decelerate and challenge stocks priced for distant demand. | · | tweet ↗ |
| 2026-08-27 | · | @LogicalThesis | · | Says the author's biotech focus is generally on cash-rich, debt-free companies. | · | tweet ↗ |
| 2026-08-27 | SRPT | @LogicalThesis | +0.60 | Reports cashing out a leveraged SRPT long for a 50% one-day gain. | · | tweet ↗ |
| 2026-08-27 | SRPT | @LogicalThesis | +0.65 | Recaps a 50% gain in SRPT calls achieved in less than one day. | · | tweet ↗ |
| 2026-08-26 | · | @LogicalThesis | · | Reports another all-time high and asserts that highs tend to lead to further highs. | · | tweet ↗ |
| 2026-08-26 | · | @LogicalThesis | · | Describes trading pre-data clinical-biotech run-ups while limiting binary-event position size. | · | tweet ↗ |
| 2026-08-26 | · | @LogicalThesis | · | Discloses that the top five positions are diagnostics and healthcare businesses rather than clinical biotech. | · | tweet ↗ |
Grade is our human read-worthiness rating; trader score is a rolling 20-bet hit-rate/alpha composite — different things, often disagreeing. “Since then” is direction-unaware in the table; the summary line above adjusts for which way they leaned.